APA

Piek A., Koonen D. P. Y., Schouten E., Lindtstedt E. L., Michaëlsson E., de Boer R. A. & Silljé H. H. W. (20201111). Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. : Scientific reports.

Chicago

Piek Arnold, Koonen Debby P Y, Schouten Elisabeth-Maria, Lindtstedt Eva L, Michaëlsson Erik, de Boer Rudolf A and Silljé Herman H W. 20201111. Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. : Scientific reports.

Harvard

Piek A., Koonen D. P. Y., Schouten E., Lindtstedt E. L., Michaëlsson E., de Boer R. A. and Silljé H. H. W. (20201111). Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. : Scientific reports.

MLA

Piek Arnold, Koonen Debby P Y, Schouten Elisabeth-Maria, Lindtstedt Eva L, Michaëlsson Erik, de Boer Rudolf A and Silljé Herman H W. Pharmacological myeloperoxidase (MPO) inhibition in an obese/hypertensive mouse model attenuates obesity and liver damage, but not cardiac remodeling. : Scientific reports. 20201111.